Inducible endothelial surface protein mediating melanoma cell ad

Details Inducible endothelial surface protein mediating melanoma cell ad Inducible endothelial surface protein mediating melanoma cell ad

1993-07-29

2000-12-26

Eyler, Yvonne

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

5303877, 5303888, C07K 100, C07K 1400, C07K 1700, C07K 1600

Patent

active

061661791

ABSTRACT:
Monoclonal antibody E1/6, or fragments thereof, blocks adhesion to the vascular endothelium of certain pathophysiological cells. Monoclonal antibody E1/6, or fragments thereof, and the glycoprotein recognized by the E1/6 antibody, are used pharmaceutically, therapeutically, and diagnostically in the treatment of these pathophysiological disorders. Compositions, methods of treating, and methods of diagnosing are disclosed.

REFERENCES:
Bevilacqua et al. J. Clin. Invest. 76:2003-2011, 1985.
Vanderheide et al. J. Exp. Med. 175:1433-1442, 1992.
Sherman-Gold, Genetic Engineering News, Jul. 1993, pp. 6, 7, 14.
Herbert et al., Eds. Dictionary of Immunology, Blackwell Scientific Publications, 1985, p. 77.

Affiliated with

Also associated with

Rating

Inducible endothelial surface protein mediating melanoma cell ad does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inducible endothelial surface protein mediating melanoma cell ad, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inducible endothelial surface protein mediating melanoma cell ad will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-996277